PERSPECTA

News from every angle

← Back to headlines

FDA Considers Staff Bonuses to Expedite Drug Reviews

The FDA is reportedly exploring the use of staff bonuses as a mechanism to accelerate the review process for new drugs.

26 Feb, 18:35 — 26 Feb, 18:35
PostShare
ℹOnly 1 source covers this story

Read at source (1 outlet)

seeking-alpha1h ago

FDA reportedly eyeing staff bonuses to accelerate drug reviews

Read full article →

Related Stories

Philippine DOH Clarifies No Penalties for Parents Refusing Child Vaccination

just now

Paradigm Shift in Back Pain Treatment: Exercise Over Medication

12m ago

Norway's King Harald V Discharged from Hospital

19m ago

Young Europeans still drawn to tobacco — WHO report

19m ago